CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Clinical trials for CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME trials appear
Sign up with your email to follow new studies for CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Childhood cancer immunotherapy trial pulled before it started
Disease control TerminatedThis study was designed to test two immunotherapy drugs, nivolumab and ipilimumab, in children and young adults with cancers that returned or didn't respond to treatment and had many genetic mutations. The goal was to see if the drug combination was safe and could shrink tumors. …
Matched conditions: CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Could an immune booster help kids fight deadly brain cancer?
Disease control OngoingThis early-stage trial is testing the safety and potential benefit of pembrolizumab, an immunotherapy drug, in 71 children whose brain tumors (like DIPG, high-grade gliomas, or medulloblastoma) have come back or not responded to standard treatments. The drug works by helping the …
Matched conditions: CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC